Related Experiment Video
Updated: Jan 8, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
The critical link between TB infection control process and clinical impact: need for efficacy data and MDR-TB
Parth Aphale1, Shashank Dokania1, Himanshu Shekhar1
1Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
Abstract:
The study by Song et al. [1] detailing the significant improvements in Tuberculosis Infection Control (TBIC) implementation rates across designated hospitals in Jiangsu Province, China, provides valuable data on the feasibility of programmatic interventions in high-burden settings. The demonstrated rise in compliance for Administrative Controls (AC), Environmental Controls (EC), and Respiratory Protection (RP) is commendable. However, as scholars focused on global TB elimination, we must constructively appraise whether measuring implementation rates adequately captures the desired public health impact, particularly in facilities designated for multi-drug resistant tuberculosis (MDR-TB).
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

